New York: Back to School—R and D in Academia
This is part 2 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
6397 RESULTS
Sort By:
This is part 2 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
This is part 1 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
Synapses, those miniscule gaps across which neurons signal one another, are far from static...
Myriad genetics presented additional 24-month data from the completed follow-on study of a phase 2 trial of its experimental Alzheimer drug...
Boosting neuronal excitation with acetylcholinesterase inhibitors is one way of tackling cognitive decline in Alzheimer disease...
Two papers last week addressed related puzzles in Huntington’s and related diseases, that is, why...
Synaptic plasticity is a contest between long-term potentiation (LTP) and long-term depression (LTD), with the...
Pat McCaffrey Interviews Randy Buckner
Congratulations are in order for this year’s winners of the MetLife Foundation Award for Medical Research in Alzheimer’s Disease...
The current issue of Neuron contains a scientific debate that bears watching...
In the 15 February Neuron, Masafumi Ihara and Makoto Kinoshita at Kyoto University in Japan reveal not one, but two critical...
As any marketing guru will tell you, getting your message to the right audience is essential if you want your business to thrive...
Recent studies have raised the troubling possibility that widely used inhaled anesthetics might exacerbate amyloid pathology...
Even as Alzheimer researchers are still mourning the sudden death of Leon Thal, news reached the ARF editors that the field has lost two more formidable physician-scientists in the past month...
In the February 9 Science, Adrian Bird and colleagues at Edinburgh University, Scotland, report striking results of a “cure” for Rett syndrome mice...
No filters selected